The paper by the ICT Patras team CLINICAL TRANSLATION OF A NOVEL, POTENT AND WELL-CHARACTERIZED INDUCED REGULATORY T-CELL PRODUCT AGAINST GRAFT VERSUS HOST DISEASE was accepted to the EHA Hybrid Congress 2023 and was awarded a travel grant.
The research laboratory of Bone Marrow Transplantation of Institute of Cell Therapy held a customary celebration for the new year with the participation of all the students and the professor A. Spyridonidis. Best wishes for a happy new year!
The 2nd practical session of the Master’s Program “Cell and Gene Therapies: from bench to bedside and Good Manufacturing Practices” (Director Prof. Alexandros Spyridonidis), took place at the facilities of the Institute of Cell Therapies (ICT) and the University of Patras was successfully completed. The
In the framework of Bodossaki Foundation’s longstanding support of the creative work of young Greek scientists, and with the aim of rewarding their dedication to the advancement of science as well as promoting outstanding role models for society, Bodossaki Foundation has established the “Distinguished Young
Dionysia Kefala, PhD candidate at the ICT, participated in the 2nd Translational Research Conference: Immune & Cellular Therapies: Focus on Advanced Gene-Engineered Immune Cells in Berlin, Germany organized by the European School of Hematology on September 12-14, 2022. Dionysia Kefala presented the study on
JOB VACANCY: “Cell Therapy Production Manager” The Institute of Cell Therapy (www.ictpatras.gr) of the University Research Center of the University of Patras (www.pek.upatras.gr) is looking for a Production Manager for the GMP Laboratory “Dimitris Lois” (https://lnkd.in/eRF6YBUx): Required qualifications: Degree holder in one of:
Scholarship Applications Now Open Submission Deadline: October 31, 2022 OVERVIEW Following the success of the 2021/2022 program, ISCT, International Society for Cell & Gene Therapy is proud to offer full tuition scholarships for 3 ISCT European Members to enroll in the 2023/2024 Master Degree or Specialization Degree
The Institute of Cell Therapy participated in the 9th International Conference on HLA-G in Paris (4&5 July 2022). The conference focused on the biology and clinical significance of the immunomodulatory molecule HLA-G in the fields of oncology, transplantation, autoimmune and other diseases. PhD candidate
The MSc in Cell and Gene Therapies accepts applications for the academic year 2022-2023. Candidates are invited to submit their application by September 12, 2022. Legislation This is a bi-institutional program of postgraduate studies of the School of Medicine of the University of Patras and the Department
Prof. Alexandros Spyridonidis, Director and Dionysia Kefala, PhD candidate of the ICT, participated in the Annual Meeting ISCT 2022 San Fransisco, California, USA in May 2022. Dionysia Kefala presented the study on “Pre-clinical development of a decitabine-induced regulatory HLAG+CD4+ T cell-enriched cell product (iG-Treg) against
